The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma.

Mohammad H Abu ArjaAustin L BrownJack M SuM Fatih OkcuHolly B LindsaySusan L McGovernMary Frances McAleerDavid R GrosshansMurali M ChintagumpalaArnold C Paulino

Published in: Neuro-oncology (2024)

Children <7 years at radiotherapy with a Dmc ≥36 Gy are at higher risk for HL.

Keyphrases

hearing loss
early stage
young adults
locally advanced
radiation therapy
radiation induced
early onset
rectal cancer
drug induced